ClinicalTrials.Veeva

Menu
S

Southcoast Research Center | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cenerimod
Permethrin
Itolizumab
KZR-616
AION-301
Estradiol
PF-07275315
Rimegepant
Ritlecitinib
BHV-3000

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 21 total trials

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

The purpose of this study is to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of nonsegmental viti...

Active, not recruiting
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to seve...

Enrolling
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Cenerimod

The goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic...

Enrolling
Lupus Erythematosus, Systemic
Nephritis, Lupus
Drug: Placebo
Drug: Cenerimod
Locations recently updated

The goal of this clinical trial is to learn about the safety (good or bad) of giving two AION-301 intravenous (IV) infusions, in adults with Stage 3...

Enrolling
Chronic Kidney Disease Stage 3
Drug: Placebo
Biological: AION-301

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe sympto...

Invitation-only
Lupus Erythematosus, Systemic
Drug: Cenerimod

The goal of this clinical trial is to learn how rifaximin 200 mg is processed in the body (pharmacokinetics) in children 6 to 11 years old with acute...

Enrolling
Diarrhea
Bacterial Infection
Drug: Rifaximin 200 mg Tablet
Other: Oral Rehydration Therapy (ORT)

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidat...

Enrolling
Acne
Other: Placebo
Biological: Acne mRNA vaccine

Trial sponsors

Pfizer logo
V
Bausch Health logo
E
I
K
K
M
Mylan logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems